Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Mar-Apr:(2):38-42.

[Experimental study on the possibility of using live tularemia vaccine to increase resistance to heterologous infection disease]

[Article in Russian]
Affiliations
  • PMID: 15188557

[Experimental study on the possibility of using live tularemia vaccine to increase resistance to heterologous infection disease]

[Article in Russian]
V I Iliukhin et al. Zh Mikrobiol Epidemiol Immunobiol. 2004 Mar-Apr.

Abstract

In experiments on guinea pigs immunized with Francisella tularensis 15, or live tularemia vaccine (LTV), the level of heterologous protective effect to dangerous infectious diseases caused by Yersinia pestis, Burkholderia pseudomallei, B. mallei, Mycobacterium tuberculosis was studied. The study revealed that during the first 4 weeks after the subcutaneous immunization with LTV the level of resistance of the immunized animals to heterologous infective agent reliably increased as indicated by the survival rate of the animals, as well as by the survival time of those killed by infection, in comparison with the controls. Later (on day 150 after immunization) differences in death rate between the groups perceptibly decreased. Nevertheless, the 1 1/2-fold increase of the survival time of the challenged immunized animals in comparison with the controls proved the possibility of using immunization with LTV for the urgent prophylaxis and treatment not only of tularemia, but also of plague, glanders, melioidosis and tuberculosis.

PubMed Disclaimer

Similar articles

Cited by

  • Burkholderia vaccines: are we moving forward?
    Choh LC, Ong GH, Vellasamy KM, Kalaiselvam K, Kang WT, Al-Maleki AR, Mariappan V, Vadivelu J. Choh LC, et al. Front Cell Infect Microbiol. 2013 Feb 5;3:5. doi: 10.3389/fcimb.2013.00005. eCollection 2013. Front Cell Infect Microbiol. 2013. PMID: 23386999 Free PMC article. Review.

MeSH terms

LinkOut - more resources